Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. - Wikidata - awgldk - TriplyDB

Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

http://www.wikidata.org/entity/Q36936570

about

Roles of the (pro)renin receptor in the kidney Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade Intratubular renin-angiotensin system in hypertension Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury.Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation.Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats.N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.Angiotensin II blockade and renal protection.Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats.Pleiotropic effects of angiotensin receptor blockers: addressing comorbidities by optimizing hypertension therapy.Renin-angiotensin system within the diabetic podocyte.Add-on aliskiren elicits stronger renoprotection than high-dose valsartan in type 2 diabetic KKAy mice that do not respond to low-dose valsartan.Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice.Elucidating mechanisms underlying altered renal autoregulation in diabetes.Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats.Renoprotective mechanisms of telmisartan on renal injury and inflammation in SHRSP.Z-Leprfa/IzmDmcr rats.

P2860

Q27026784-D53AB549-A5ED-4789-A8B8-AF6024AAE1DA Q33714897-9E0D6B1A-22C5-4995-8946-A7C043B1A110 Q33887622-75A5C37A-289E-48E6-84A4-85BE7CAFA0AB Q34203622-7C0F7FDA-E9DD-4420-A5C4-288ED8DE32DE Q34777649-E3DA15CA-6427-47CD-B557-AED0E4984C92 Q35436998-7E6EC5F0-433D-438B-AF54-424C62BFA485 Q35842921-DE1864B5-6112-40FA-8B63-A03C2478A101 Q35894709-6455454B-60A8-4352-BDBC-633BC704DDAD Q36236587-641E99D0-0CE2-4962-B62A-3CD09AB42CC5 Q36236725-A51C0A56-C7CC-4DE1-B939-90323E3D1734 Q36449123-CFA98F3A-A19F-4926-81CB-2C50CA3711DF Q36561841-DF83619F-7472-4F90-8C6D-A6B190BD70B2 Q36836004-76D02D66-3A00-442D-9821-C9ACE2EB4F29 Q36847492-05BA0FED-E9BE-48FF-BC81-C72ADE5981EE Q37826797-180D4DF3-823E-459B-AF35-7B88B598A669 Q38262105-E86851F0-6A32-47C2-B88D-32D23C6051F4 Q41998504-36DAC3A1-4C4C-4735-9F7C-CF170E74CC84 Q42925812-84C09764-E294-45DC-A8AC-7EA1380C093A Q43900303-612418B4-F901-4195-B83B-8D9E220F5DB9 Q47393307-EB2AC987-662D-4E6C-92B8-3AF21ECE6998 Q53696333-3EBF9DC0-7926-4521-A320-79C6B2CE2097 Q54463435-06D25D26-BD56-450E-B205-BEEE58036B0A

P2860

Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

http://www.wikidata.org/entity/Q36936570

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Strict angiotensin blockade pr ...... ic rats with microalbuminuria.

@en

type

label

Strict angiotensin blockade pr ...... ic rats with microalbuminuria.

@en

prefLabel

Strict angiotensin blockade pr ...... ic rats with microalbuminuria.

@en

P1433

Q36936570-8E256986-1C9F-4B0B-A65F-F566650F22C1

P1476

Q36936570-CD945014-DA80-49B8-9ADF-34F4FCE176FC

P2093

Q36936570-079E2427-7F56-4F5C-BB85-F10259C2994F

Q36936570-1D7363AE-9A7D-4888-AACF-9FD95E2441D3

Q36936570-31E0D3EC-8815-413D-ADBF-55855A8FA0DB

Q36936570-39910517-FFEF-4FA4-B8D5-FC05DDD3D6C8

Q36936570-4608E466-A03E-49C8-B94E-147FE6383C89

Q36936570-4CAC7877-89AB-4A2B-A713-82A6ECF0D546

Q36936570-8CEE6605-16D2-44F8-ADFD-2780787A94B9

Q36936570-A99DB8EE-1957-4B86-B911-594C7233572E

Q36936570-B200D0A4-DF40-4D95-8A0F-AB46D0C4E4D3

Q36936570-CD4411B4-4D70-4AF3-BC5F-40CB50116205

P2860

Q36936570-14A9BBD4-4651-40FC-AE2C-8FF62070C2D4

Q36936570-19EC32E0-6439-4A81-A398-1576B2B06F0B

Q36936570-1D407B62-00E7-46C9-96D0-519D91ECEC66

Q36936570-1F7D5C08-050E-437E-A9AD-6AA3911E20F3

Q36936570-2076C66E-7B7D-4DA3-AD5A-66411032467B

Q36936570-2EA75A6C-4B6E-4EEE-849B-9A1C0278AB09

Q36936570-390E1D0C-EBDD-401B-88E1-4EC4E0C5331F

Q36936570-39E8071F-F34D-4598-AD9B-95FBF94E3FDC

Q36936570-40861312-D295-434E-85CB-080A465B98E0

Q36936570-414CAD17-4EC9-4BCE-A717-AAC6938E03E6

P304

Q36936570-65ED10E9-C755-4257-8D5D-6C536971D7B0

P31

Q36936570-AF5DE4BD-6618-4252-B99F-CFE2E05FA4C4

P356

Q36936570-EAF64773-DFDD-4510-81B1-849BC82FA481

P433

Q36936570-13315DD5-D994-4B3D-B6C9-AF746F6F3360

P478

Q36936570-07D62147-54A9-4FD9-B357-8608546F0C7A

P50

Q36936570-03A517D7-3457-4F8C-A049-0E56E65D7437

Q36936570-DA4BC89E-835F-4D86-A8B8-F89D38C0595A

P577

Q36936570-37D25954-498A-44C3-8C23-5B49FF14FA56

P698

Q36936570-3AFD6D65-9CB2-4627-A5BC-E34D835C8702

P932

Q36936570-B4596884-B857-4DF6-9241-ACE220890308

P356

HJH.0B013E3283060EFA

P1433

Journal of Hypertension

P1476

Strict angiotensin blockade pr ...... tic rats with microalbuminuria

@en

P2093

Akira Nishiyama

http://www.w3.org/2001/XMLSchema#string

Hideyasu Kiyomoto

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kobori

http://www.w3.org/2001/XMLSchema#string

Isseiki Meda

http://www.w3.org/2001/XMLSchema#string

Masahito Imanishi

http://www.w3.org/2001/XMLSchema#string

Michiaki Okumura

http://www.w3.org/2001/XMLSchema#string

Noriyuki Okada

http://www.w3.org/2001/XMLSchema#string

Takashi Morikawa

http://www.w3.org/2001/XMLSchema#string

Takefumi Mori

http://www.w3.org/2001/XMLSchema#string

Toshitaka Nakagawa

http://www.w3.org/2001/XMLSchema#string

P2860

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss

Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats.

Preventing microalbuminuria in type 2 diabetes.

Remission and regression of diabetic nephropathy.

Why are angiotensin concentrations so high in the kidney?

Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall.

Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats.

P304

1849-1859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/HJH.0B013E3283060EFA

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18698221

http://www.w3.org/2001/XMLSchema#string

P932

2567283

http://www.w3.org/2001/XMLSchema#string